Antiviral therapy decreases recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection: a meta-analysis (Q38208945)

31 August 2017

0 references

Antiviral therapy decreases recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection: a meta-analysis (English)

1 reference

31 August 2017

1 reference

hepatocellular carcinoma

1 reference

1 reference

1 reference

Yanming Zhou

1

1 reference

31 August 2017

Zhansai Zhang

2

1 reference

31 August 2017

Yanfang Zhao

3

1 reference

31 August 2017

Lupeng Wu

4

1 reference

31 August 2017

Bin Li

5

1 reference

31 August 2017

1 September 2014

1 reference

31 August 2017

World Journal of Surgery

1 reference

31 August 2017

38

1 reference

31 August 2017

9

1 reference

31 August 2017

2395-2402

1 reference

https://scigraph.springernature.com/pub.10.1007/s00268-014-2586-z

31 August 2017

0 references

cites work

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Laparoscopic versus open hepatic resections for benign and malignant neoplasms--a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Practical methods for incorporating summary time-to-event data into meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

High hepatitis B viral load predicts recurrence of small hepatocellular carcinoma after curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

High HBV-DNA titer in surrounding liver rather than in hepatocellular carcinoma tissue predisposes to recurrence after curative surgical resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Effect of antiviral treatment with nucleotide/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Viral hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Long-term results of a randomized, observation-controlled, phase III trial of adjuvant interferon Alfa-2b in hepatocellular carcinoma after curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Significance of viral status on recurrence of hepatitis B-related hepatocellular carcinoma after curative therapy: A meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

Meta-analysis of pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-014-2586-Z

A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma

1 reference

12 December 2020

Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma

1 reference

12 December 2020

Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma

1 reference

12 December 2020

Sustained low hepatitis B viral load predicts good outcome after curative resection in patients with hepatocellular carcinoma

1 reference

12 December 2020

Lamivudine treatment in patients with HBV-related hepatocellular carcinoma--using an untreated, matched control cohort

1 reference

12 December 2020

Chronic hepatitis B and hepatocarcinogenesis: does prevention of "collateral damage" bring the cure?

1 reference

12 December 2020

Nucleotide analogs for patients with HBV-related hepatocellular carcinoma increase the survival rate through improved liver function

1 reference

12 December 2020

10.1007/S00268-014-2586-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

0 references

1 reference